Your browser doesn't support javascript.
loading
Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4+ Infant ALL.
Bardini, Michela; Trentin, Luca; Rizzo, Francesca; Vieri, Margherita; Savino, Angela M; Garrido Castro, Patricia; Fazio, Grazia; Van Roon, Eddy H J; Kerstjens, Mark; Smithers, Nicholas; Prinjha, Rab K; Te Kronnie, Geertruy; Basso, Giuseppe; Stam, Ronald W; Pieters, Rob; Biondi, Andrea; Cazzaniga, Gianni.
Affiliation
  • Bardini M; Centro Ricerca Tettamanti, Pediatric Clinic, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy. michela.bardini@unimib.it.
  • Trentin L; Department of Medicine, University of Milano-Bicocca, Milano, Italy.
  • Rizzo F; Department of Woman and Child Health, University of Padua, Padua, Italy.
  • Vieri M; Centro Ricerca Tettamanti, Pediatric Clinic, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy.
  • Savino AM; Centro Ricerca Tettamanti, Pediatric Clinic, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy.
  • Garrido Castro P; Centro Ricerca Tettamanti, Pediatric Clinic, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy.
  • Fazio G; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Van Roon EHJ; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Kerstjens M; Centro Ricerca Tettamanti, Pediatric Clinic, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy.
  • Smithers N; Department of Medicine, University of Milano-Bicocca, Milano, Italy.
  • Prinjha RK; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Te Kronnie G; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Basso G; Epinova DPU, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Medicines Research Centre, Stevenage, Hertfordshire, England, United Kingdom.
  • Stam RW; Epinova DPU, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Medicines Research Centre, Stevenage, Hertfordshire, England, United Kingdom.
  • Pieters R; Department of Woman and Child Health, University of Padua, Padua, Italy.
  • Biondi A; Department of Woman and Child Health, University of Padua, Padua, Italy.
  • Cazzaniga G; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
Mol Cancer Ther ; 17(8): 1705-1716, 2018 08.
Article in En | MEDLINE | ID: mdl-29748211
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myeloid-Lymphoid Leukemia Protein / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Guideline Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2018 Document type: Article Affiliation country: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myeloid-Lymphoid Leukemia Protein / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Guideline Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2018 Document type: Article Affiliation country: Italy